These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
171 related articles for article (PubMed ID: 38324876)
1. Multiple myeloma and Chagas disease: qPCR as a marker for preemptive antiparasitic therapy: a case reports series and review. Carvalho NB; Freitas VLT; Seguro FS; Bezerra RC; Fatobene G; Nakanishi ÉYS; Visnadi H; Martinez G; Batista MV; Rocha V; Dulley FL; Costa SF; Shikanai-Yasuda MA Rev Inst Med Trop Sao Paulo; 2024; 66():e10. PubMed ID: 38324876 [TBL] [Abstract][Full Text] [Related]
2. Quantitative PCR as a marker for preemptive therapy and its role in therapeutic control in Trypanosoma cruzi/HIV coinfection. Freitas VLT; Novaes CTG; Sartori AMC; Carvalho NB; Silva SCVD; Nakanishi ÉS; Salvador F; Castro CN; Bezerra RC; Westphalen EVN; Oliveira CMR; Busser FD; Ho YL; Buccheri R; Bonilla C; Shikanai-Yasuda MA PLoS Negl Trop Dis; 2024 Feb; 18(2):e0011961. PubMed ID: 38408095 [TBL] [Abstract][Full Text] [Related]
3. Aplastic Anemia and Chagas Disease: Carvalho NB; de Freitas VT; Bezerra RC; Nakanishi ES; Velloso EP; Higashino HR; Batista MV; Fonseca GH; Rocha V; Costa SF; Shikanai-Yasuda MA Trop Med Infect Dis; 2022 Sep; 7(10):. PubMed ID: 36288009 [TBL] [Abstract][Full Text] [Related]
4. Chagas disease and liver transplantation: Experience in Argentina using real-time quantitative PCR for early detection and treatment. Balderramo D; Bonisconti F; Alcaraz A; Giordano E; Sánchez A; Barrabino M; Caeiro JP; Alvarellos T; Maraschio M Transpl Infect Dis; 2017 Dec; 19(6):. PubMed ID: 28941300 [TBL] [Abstract][Full Text] [Related]
5. Course of Chronic Trypanosoma cruzi Infection after Treatment Based on Parasitological and Serological Tests: A Systematic Review of Follow-Up Studies. Sguassero Y; Cuesta CB; Roberts KN; Hicks E; Comandé D; Ciapponi A; Sosa-Estani S PLoS One; 2015; 10(10):e0139363. PubMed ID: 26436678 [TBL] [Abstract][Full Text] [Related]
6. HIV and Chagas Disease: An Evaluation of the Use of Real-Time Quantitative Polymerase Chain Reaction to Measure Levels of Trypanosoma cruzi Parasitemia in HIV Patients in Cochabamba, Bolivia. Reimer-McAtee MJ; Mejia C; Clark T; Terle J; Pajuelo MJ; Cabeza J; Lora MH; Valencia E; Castro R; Lozano D; Bern C; Torrico F; Gilman RH Am J Trop Med Hyg; 2021 Aug; 105(3):643-650. PubMed ID: 34398818 [TBL] [Abstract][Full Text] [Related]
7. Towards the establishment of a consensus real-time qPCR to monitor Trypanosoma cruzi parasitemia in patients with chronic Chagas disease cardiomyopathy: a substudy from the BENEFIT trial. Moreira OC; Ramírez JD; Velázquez E; Melo MF; Lima-Ferreira C; Guhl F; Sosa-Estani S; Marin-Neto JA; Morillo CA; Britto C Acta Trop; 2013 Jan; 125(1):23-31. PubMed ID: 22982466 [TBL] [Abstract][Full Text] [Related]
8. Antitrypanosomal Treatment with Benznidazole Is Superior to Posaconazole Regimens in Mouse Models of Chagas Disease. Khare S; Liu X; Stinson M; Rivera I; Groessl T; Tuntland T; Yeh V; Wen B; Molteni V; Glynne R; Supek F Antimicrob Agents Chemother; 2015 Oct; 59(10):6385-94. PubMed ID: 26239982 [TBL] [Abstract][Full Text] [Related]
9. Could pre-infection exercise training improve the efficacy of specific antiparasitic chemotherapy for Chagas disease? Santos EG; Gonçalves RV; Souza-Silva TG; Maldonado IRSC; Santos EC; Talvani A; Natali AJ; Novaes RD Parasitology; 2019 Nov; 146(13):1655-1664. PubMed ID: 31362797 [TBL] [Abstract][Full Text] [Related]
10. Therapeutic effects of benznidazole in Swiss mice that are orally inoculated with Trypanosoma cruzi IV strains from the Western Brazilian Amazon. Teston APM; Fernandes NS; Abegg CP; de Abreu AP; Sarto MPM; Gomes ML; Toledo MJO Exp Parasitol; 2021 Sep; 228():108136. PubMed ID: 34280400 [TBL] [Abstract][Full Text] [Related]
11. Parasitemia Levels in Trypanosoma cruzi Infection in Spain, an Area Where the Disease Is Not Endemic: Trends by Different Molecular Approaches. Flores-Chavez MD; Abras A; Ballart C; Ibáñez-Perez I; Perez-Gordillo P; Gállego M; Muñoz C; Moure Z; Sulleiro E; Nieto J; García Diez E; Simón L; Cruz I; Picado A Microbiol Spectr; 2022 Oct; 10(5):e0262822. PubMed ID: 36190410 [TBL] [Abstract][Full Text] [Related]
12. Trypanocidal drugs for late-stage, symptomatic Chagas disease (Trypanosoma cruzi infection). Vallejo M; Reyes PP; Martinez Garcia M; Gonzalez Garay AG Cochrane Database Syst Rev; 2020 Dec; 12(12):CD004102. PubMed ID: 33305846 [TBL] [Abstract][Full Text] [Related]
13. An in vitro iron superoxide dismutase inhibitor decreases the parasitemia levels of Trypanosoma cruzi in BALB/c mouse model during acute phase. Olmo F; Urbanová K; Rosales MJ; Martín-Escolano R; Sánchez-Moreno M; Marín C Int J Parasitol Drugs Drug Resist; 2015 Dec; 5(3):110-6. PubMed ID: 26236582 [TBL] [Abstract][Full Text] [Related]
14. Use of a Chagas Urine Nanoparticle Test (Chunap) to Correlate with Parasitemia Levels in T. cruzi/HIV Co-infected Patients. Castro-Sesquen YE; Gilman RH; Mejia C; Clark DE; Choi J; Reimer-McAtee MJ; Castro R; Valencia-Ayala E; Flores J; Bowman N; Castillo-Neyra R; Torrico F; Liotta L; Bern C; Luchini A; PLoS Negl Trop Dis; 2016 Feb; 10(2):e0004407. PubMed ID: 26919324 [TBL] [Abstract][Full Text] [Related]
15. Sesquiterpene lactone potentiates the immunomodulatory, antiparasitic and cardioprotective effects on anti-Trypanosoma cruzi specific chemotherapy. Gonçalves-Santos E; Vilas-Boas DF; Diniz LF; Veloso MP; Mazzeti AL; Rodrigues MR; Oliveira CM; Fernandes VHC; Novaes RD; Chagas-Paula DA; Caldas IS Int Immunopharmacol; 2019 Dec; 77():105961. PubMed ID: 31685438 [TBL] [Abstract][Full Text] [Related]
16. Low-dose benznidazole treatment results in parasite clearance and attenuates heart inflammatory reaction in an experimental model of infection with a highly virulent Trypanosoma cruzi strain. Cevey ÁC; Mirkin GA; Penas FN; Goren NB Int J Parasitol Drugs Drug Resist; 2016 Apr; 6(1):12-22. PubMed ID: 26862474 [TBL] [Abstract][Full Text] [Related]